Merck, Otsuka Make R&D Pact for Buzzed-About Cancer Target

January 7, 2020

Merck & Co. will pay $50 million, plus as much as $2.5 billion in potential future payments, in a research and development deal with Otsuka Pharmaceutical Co. that includes a much-talked-about drug targeting a dangerous subset of cancers.